Glucagon‐Like Peptide‐1 Receptor Agonist Therapy Is Associated With Improvement in Psoriatic Arthritis–Related and Metabolic Outcomes: A Retrospective Analysis of Two Cohorts
Rebecca H. Haberman,
Alexandra L. Rice,
Kyra Chen,
Uma Scher,
Sydney Thib,
Jose U. Scher,
Lihi Eder
Wiley ·
2026-10-27
· DOI 10.1002/art.70170
⬢ Cited by: 7Crossref
The publisher did not provide an abstract — full text is available via the link below.
Rebecca H. Haberman, Alexandra L. Rice, Kyra Chen, Uma Scher, Sydney Thib, Jose U. Scher et al. Glucagon‐Like Peptide‐1 Receptor Agonist Therapy Is Associated With Improvement in Psoriatic Arthritis–Related and Metabolic Outcomes: A Retrospective Analysis of Two Cohorts. // Arthritis and Rheumatology. – 2026. – DOI: 10.1002/art.70170. – URL: https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.70170?af=R
Rebecca H. Haberman, Alexandra L. Rice, Kyra Chen, Uma Scher, Sydney Thib, Jose U. Scher, & Lihi Eder (2026). Glucagon‐Like Peptide‐1 Receptor Agonist Therapy Is Associated With Improvement in Psoriatic Arthritis–Related and Metabolic Outcomes: A Retrospective Analysis of Two Cohorts. Arthritis and Rheumatology. https://doi.org/10.1002/art.70170
Rebecca H. Haberman, et al. “Glucagon‐Like Peptide‐1 Receptor Agonist Therapy Is Associated With Improvement in Psoriatic Arthritis–Related and Metabolic Outcomes: A Retrospective Analysis of Two Cohorts.” Arthritis and Rheumatology, 2026. doi:10.1002/art.70170.
@article{Haberman2026,
title = {Glucagon‐Like Peptide‐1 Receptor Agonist Therapy Is Associated With Improvement in Psoriatic Arthritis–Related and Metabolic Outcomes: A Retrospective Analysis of Two Cohorts},
author = {Haberman, Rebecca H. and Rice, Alexandra L. and Chen, Kyra and Scher, Uma and Thib, Sydney and Scher, Jose U. and Eder, Lihi},
journal = {Arthritis and Rheumatology},
year = {2026},
doi = {10.1002/art.70170},
url = {https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.70170?af=R}
}